These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35065958)

  • 1. Can two wrongs make a right? F508del-CFTR ion channel rescue by second-site mutations in its transmembrane domains.
    Prins S; Corradi V; Sheppard DN; Tieleman DP; Vergani P
    J Biol Chem; 2022 Mar; 298(3):101615. PubMed ID: 35065958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Comparative Modeling of Multi-Domain F508del CFTR.
    McDonald EF; Woods H; Smith ST; Kim M; Schoeder CT; Plate L; Meiler J
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated biophysical studies implicate partial unfolding of NBD1 of CFTR in the molecular pathogenesis of F508del cystic fibrosis.
    Wang C; Protasevich I; Yang Z; Seehausen D; Skalak T; Zhao X; Atwell S; Spencer Emtage J; Wetmore DR; Brouillette CG; Hunt JF
    Protein Sci; 2010 Oct; 19(10):1932-47. PubMed ID: 20687163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-native Conformers of Cystic Fibrosis Transmembrane Conductance Regulator NBD1 Are Recognized by Hsp27 and Conjugated to SUMO-2 for Degradation.
    Gong X; Ahner A; Roldan A; Lukacs GL; Thibodeau PH; Frizzell RA
    J Biol Chem; 2016 Jan; 291(4):2004-2017. PubMed ID: 26627832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of Phenylalanine 508 in the First Nucleotide-binding Domain of the Cystic Fibrosis Transmembrane Conductance Regulator Increases Conformational Exchange and Inhibits Dimerization.
    Chong PA; Farber PJ; Vernon RM; Hudson RP; Mittermaier AK; Forman-Kay JD
    J Biol Chem; 2015 Sep; 290(38):22862-78. PubMed ID: 26149808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of NBD1 thermal stability is necessary and sufficient to correct ∆F508 CFTR folding and assembly.
    He L; Aleksandrov AA; An J; Cui L; Yang Z; Brouillette CG; Riordan JR
    J Mol Biol; 2015 Jan; 427(1):106-20. PubMed ID: 25083918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decoding F508del misfolding in cystic fibrosis.
    Wang XR; Li C
    Biomolecules; 2014 May; 4(2):498-509. PubMed ID: 24970227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solubilizing mutations used to crystallize one CFTR domain attenuate the trafficking and channel defects caused by the major cystic fibrosis mutation.
    Pissarra LS; Farinha CM; Xu Z; Schmidt A; Thibodeau PH; Cai Z; Thomas PJ; Sheppard DN; Amaral MD
    Chem Biol; 2008 Jan; 15(1):62-9. PubMed ID: 18215773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1.
    Ren HY; Grove DE; De La Rosa O; Houck SA; Sopha P; Van Goor F; Hoffman BJ; Cyr DM
    Mol Biol Cell; 2013 Oct; 24(19):3016-24. PubMed ID: 23924900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms.
    Roxo-Rosa M; Xu Z; Schmidt A; Neto M; Cai Z; Soares CM; Sheppard DN; Amaral MD
    Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17891-6. PubMed ID: 17098864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing conformational rescue induced by a chemical corrector of F508del-cystic fibrosis transmembrane conductance regulator (CFTR) mutant.
    Yu W; Kim Chiaw P; Bear CE
    J Biol Chem; 2011 Jul; 286(28):24714-25. PubMed ID: 21602569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new 9-alkyladenine-cyclic methylglyoxal diadduct activates wt- and F508del-cystic fibrosis transmembrane conductance regulator (CFTR) in vitro and in vivo.
    Boucherle B; Bertrand J; Maurin B; Renard BL; Fortuné A; Tremblier B; Becq F; Norez C; Décout JL
    Eur J Med Chem; 2014 Aug; 83():455-65. PubMed ID: 24992073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the mechanism of action of RDR01752, a novel corrector of F508del-CFTR.
    Lopes-Pacheco M; Silva IAL; Turner MJ; Carlile GW; Sondo E; Thomas DY; Pedemonte N; Hanrahan JW; Amaral MD
    Biochem Pharmacol; 2020 Oct; 180():114133. PubMed ID: 32628927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rescue of Mutant CFTR Trafficking Defect by the Investigational Compound MCG1516A.
    Lopes-Pacheco M; Bacalhau M; Ramalho SS; Silva IAL; Ferreira FC; Carlile GW; Thomas DY; Farinha CM; Hanrahan JW; Amaral MD
    Cells; 2022 Jan; 11(1):. PubMed ID: 35011698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into structure and function of bis-phosphinic acid derivatives and implications for CFTR modulation.
    Bitam S; Elbahnsi A; Creste G; Pranke I; Chevalier B; Berhal F; Hoffmann B; Servel N; Baatalah N; Tondelier D; Hatton A; Moquereau C; Faria Da Cunha M; Pastor A; Lepissier A; Hinzpeter A; Mornon JP; Prestat G; Edelman A; Callebaut I; Gravier-Pelletier C; Sermet-Gaudelus I
    Sci Rep; 2021 Mar; 11(1):6842. PubMed ID: 33767236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correctors of the Major Cystic Fibrosis Mutant Interact through Membrane-Spanning Domains.
    Laselva O; Molinski S; Casavola V; Bear CE
    Mol Pharmacol; 2018 Jun; 93(6):612-618. PubMed ID: 29618585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two Small Molecules Restore Stability to a Subpopulation of the Cystic Fibrosis Transmembrane Conductance Regulator with the Predominant Disease-causing Mutation.
    Meng X; Wang Y; Wang X; Wrennall JA; Rimington TL; Li H; Cai Z; Ford RC; Sheppard DN
    J Biol Chem; 2017 Mar; 292(9):3706-3719. PubMed ID: 28087700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of Phe508 in the first nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator increases its affinity for the heat shock cognate 70 chaperone.
    Scott-Ward TS; Amaral MD
    FEBS J; 2009 Dec; 276(23):7097-109. PubMed ID: 19878303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508.
    deCarvalho AC; Ndi CP; Tsopmo A; Tane P; Ayafor J; Connolly JD; Teem JL
    Mol Med; 2002 Feb; 8(2):75-87. PubMed ID: 12080183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting F508del-CFTR to develop rational new therapies for cystic fibrosis.
    Cai ZW; Liu J; Li HY; Sheppard DN
    Acta Pharmacol Sin; 2011 Jun; 32(6):693-701. PubMed ID: 21642944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.